Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RHC 80267 (U-57908) is a selective inhibitor of DAGL (IC50 : 4 μM in canine platelets)
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 44.00 | |
10 mg | In stock | $ 72.00 | |
25 mg | In stock | $ 147.00 | |
50 mg | In stock | $ 246.00 | |
100 mg | In stock | $ 369.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 66.00 |
Description | RHC 80267 (U-57908) is a selective inhibitor of DAGL (IC50 : 4 μM in canine platelets) |
Targets&IC50 | DAGL:4 µM in canine platelets |
In vitro | RHC-80267 is thought to initiate activation of protein kinase C.2?At 0.3-1 μM, it has been reported to enhance acetylcholine-induced smooth muscle relaxation?in vitro |
Synonyms | U-57908 |
Molecular Weight | 394.51 |
Formula | C20H34N4O4 |
CAS No. | 83654-05-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (63.37 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RHC 80267 83654-05-1 Immunology/Inflammation Metabolism Neuroscience Others Phospholipase COX Acyltransferase AChR U 57908 RHC80267 mAChR Platelet mono- acylglycerol acyltransferase RHC-80267 Cyclooxygenase acyl-CoA:cholesterol acyltransferase diacylglycerol U57908 inhibit elaxation Diglyceride acyltransferase canine Muscarinic acetylcholine receptor Diacylglycerol acyltransferase rat acetylcholine pulmonary arteries lipase Inhibitor U-57908 inhibitor